FDA Drug · D-0525-2025

Omeprazole Delayed-release Capsules, USP, 20mg, 1000-count bottle, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, Manufactured for: Qualient Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands, NDC 82009-022-10. NDC 82009-022-10

Class II · Ongoing

Presence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules.

Affected lots / codes — check yours against thisLot: C2403017, Exp 12/31/2026

Recalling firm: Dr. Reddy's Laboratories, Inc., Princeton, NJ
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 1476 bottles
Distribution: USA Nationwide
Recall initiated: June 30, 2025
Classified: July 14, 2025
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0525-2025%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →